Orteq company

Orteq was established in 2005 to develop and commercialize bioengineering solutions for orthopaedic injuries. Orteq has developed a biodegradable, biocompatible polymer implant, Actifit, specifically designed to promote tissue ingrowth and regeneration in the meniscus, a fibrocartilage cushion in the knee. The company develops innovative healthcare products for the arthroscopic sports medicine surgeon that encourage the body’s own natural healing process. Orteq is headquartered in London.
Technology: Regenerative Medicine
Industry: Biotechnology, Health Care, Manufacturing, Science and Engineering, Sports
Headquarters: London, England, United Kingdom
Founded Date: 2005-01-01
Employees Number: 501-1000
Investors Number: 2
Total Funding: £8M
Estimated Revenue: $1M to $10M
Last Funding Type: Undisclosed

Visit Website
info@orteq.com
http://twitter.com/Orteq
Register and Claim Ownership